Trial intelligence / Profile preview

Insuman in type 2 diabetes

NCT01630369Phase 4Completed

Sponsor
Sanofi
Start
Feb 2012
Primary completion
May 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2012; status: completed.

02

Drugs

insulin human
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01630369.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01630369.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call